CBCC Global Research
Private Company
Funding information not available
Overview
CBCC Global Research is a US-headquartered, India-centric CRO founded in 2010, offering end-to-end clinical development services. It leverages its extensive site network and over 275 professionals in the US and India to execute trials, boasting experience in over 250 trials across 400+ sites. The company is positioned as a 'rescue trial' expert and is undergoing a strategic rebrand to REV Clinical, indicating a potential shift in market positioning and service offerings.
Technology Platform
Integrated clinical trial service platform encompassing Phase I-IV trial management, regulatory affairs, biometrics, medical writing, and specialized patient-based PK/BE studies. Leverages an extensive network of 500+ clinical sites and operational processes optimized for the Indian and global trial environment.
Opportunities
Risk Factors
Competitive Landscape
CBCC Global operates in the highly competitive global CRO market, competing with large multinational firms (e.g., IQVIA, Parexel, ICON) and a crowded field of regional Indian CROs. Its differentiation is based on its deep India operational expertise, full-service offering, therapeutic specialization, and 'rescue trial' capabilities.